Economy
Business·Industry
[Breaking News] SK Hanik to Invest 54 Trillion Won… Construction of Yongin Phase 2 Fab and Cheongju M17
SK hynix announced on the 7th that, following a board resolution, it has decided to invest a total of 54 trillion won—35.2 trillion won in the construction of its second-phase fab in Yongin and 19.1 t…
Business·Industry
“HBM Alone Is Not Enough”… SK hynix Proposes ‘Tiered Memory’ Combining HBF and CXL
SK hynix has unveiled a “tiered memory” solution that combines not only High-Bandwidth Memory (HBM) but also DRAM, High-Bandwidth Flash (HBF)—the next-generation NAND—and enterprise solid-state drives…
Business·Industry
15% Tariff on U.S. Polysilicon… Good News or Bad News for Korea?
With the U.S. set to impose a 15% tariff on polysilicon derivatives, the supply chain—which has been dominated by Chinese companies—is expected to rapidly restructure. Domestic materials companies tha…
Business·Industry
[Expert Insight] Min Kyung-jun, Director of Newmin Hospital: “The Paradigm in Joint Treatment Is Shifting Toward ‘Conservation’… Keep an Eye on CartiLife”
“Knee cartilage lacks blood vessels, so once damaged, it is difficult to recover naturally. Rather than enduring the pain, it is important to accurately diagnose the extent of the damage and choose a …
Business·Industry
Wise birds Inc. Reports 125% Year-Over-Year Surge in First-Half Operating Profit... “Expecting Record-High Results in the Second Half as Well”
Wise birds Inc.(273060)has successfully turned its business around, posting its best-ever half-year results in the first half of this year since the company’s founding. Wise birds Inc. announced on th…
Business·Industry
D&D Pharmatech Plummets 18% After Pfizer Halts ORALINK Candidate [K-bio pulse]
D&D Pharmatech shares fell sharply after it was confirmed that development had been halted on an obesity drug candidate built using the company’s technology. Coming on the heels of questions about Pep…
Business·Industry
D&D Pharmatech Inc. Falls 18% Despite Clarification… ‘Expectations for K’s Obesity Treatment’ Shaken [Bio Spotlight]
D&D Pharmatech Inc.’s stock price fell sharply after it was confirmed that research and development on an obesity treatment candidate incorporating D&D Pharmatech Inc.(347850)’s technology had been su…
Bonds·FX Policy
“Credit Ratings Are Not Guarantees of Principal… Investor Perceptions Must Also Change”
There are calls for the public to recognize that credit ratings are not a guarantee of principal repayment on corporate bonds, but rather an indicator of a company’s risk of default. While credit rati…
Bonds·FX Policy
Calls for Regulations on Subprime Bond Issuance… A Rigorously Designed Sales Process Is the Most Realistic Approach
Amid allegations of improper sales of JTBC corporate bonds, some observers are calling for higher barriers to entry in the sub-investment-grade corporate bond market. However, corporate bond market ex…
Financing
[Market In] Battery Pouches Soared, but It’s ‘Awkward’… YoulchonChemical Sees Both Core and New Businesses Plunge
YoulchonChemical(008730)has expressed its commitment to expanding its pouch battery business—a new growth engine—but finds itself in an awkward position as its core indicator, export performance, has …